PTP1B-IN-2
CAS No. 1919853-46-5
PTP1B-IN-2( PTP1B-IN-2 | PTP1B-IN-2 | MDK3465 )
Catalog No. M18177 CAS No. 1919853-46-5
PTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 470 | In Stock |
|
| 100MG | 683 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePTP1B-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
-
DescriptionMDK3465, also known as PTP1B-IN-2, is a potent and selective protein tyrosine phosphatase-1B (PTP1B) inhibitor. MDK3465 has CAS#1919853-46-5. The last 4 digit of its CAS# is used for name.
-
In Vitro——
-
In Vivo——
-
SynonymsPTP1B-IN-2 | PTP1B-IN-2 | MDK3465
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorPTP1B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1919853-46-5
-
Formula Weight680.79
-
Molecular FormulaC34H36N2O9S2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 146.89 mM
-
SMILESCC1=CC=C(C=C1)COC2=C(C=C(C=C2)N(CC3=CC=C(C=C3)N(CC(=O)OC)S(=O)(=O)C)S(=O)(=O)CC4=CC=CC=C4)C(=O)OC
-
Chemical Namemethyl 5-((4-((N-(4-(N-(2-methoxy-2-oxoethyl)methylsulfonamido)benzyl)-1-phenylmethyl)sulfonamido)phenoxy)methyl)-2-methylbenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Xentuzumab
Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
-
B-Raf inhibitor 1 di...
B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor.
-
Arnicolide D
Arnicolide D is a sesquiterpene lactone. Arnicolide D isolates from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner. Arnicolide D exerts strong cytotoxic activity on the human colon carcinoma HT-29 cell line.
Cart
sales@molnova.com